9:22 AM
Leo Group India
| ||
| Viacom to Replace Teva Pharmaceutical on Nasdaq-100 Index Bloomberg Viacom Inc. (VIAB) was picked to replace Teva Pharmaceutical Industries Ltd. (TEVA) in the Nasdaq-100 Index (NDX), six months after the company moved its stock listing to the Nasdaq Stock Market from the New York Stock Exchange. See all stories on this topic » | ||
| Catalyst Pharmaceutical To Sell 6 Million Units At 80 Cents Each Wall Street Journal Catalyst Pharmaceutical Partners Inc. (CPRX) is offering 6 million units in an effort to raise $4 million to fund the development of its treatments for cocaine addiction and epilepsy. The biopharmaceutical company's shares were down 17% at 72 cents in ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners Prices Underwritten Offering MarketWatch (press release) CORAL GABLES, Fla., May 24, 2012 (GlobeNewswire via COMTEX) -- Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) today announced the pricing of an underwritten offering of 6000000 units, with each unit consisting of one share of its common stock and ... See all stories on this topic » | ||
| Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal MarketWatch (press release) MONTREAL, Quebec, May 24, 2012 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. announced today that Valeant has agreed to acquire certain assets from Swiss Herbal Remedies Limited, a nutraceutical company that manufactures and ... See all stories on this topic » | ||
| REMS Research Highlights Pharmaceutical Industry Trends in Supporting Risk ... MarketWatch (press release) CHAPEL HILL, NC, May 24, 2012 /PRNewswire via COMTEX/ -- With regulators focused on the safety of new products, pharmaceutical organizations face increasing regulatory requirements for their new products. One of the outgrowths of these new regulations ... See all stories on this topic » | ||
| Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D Sacramento Bee By NanoSmart Pharmaceuticals, Inc. ORANGE COUNTY, Calif., May 24, 2012 -- /PRNewswire/ -- Dr. James Smith, President of NanoSmart Pharmaceuticals, Inc., a California corporation developing a novel drug-delivery platform for cancer pharmaceuticals, ... See all stories on this topic » | ||
| Analysis: Drugmakers vulnerable if health law revoked Reuters By Deena Beasley | LOS ANGELES (Reuters) - Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the US Supreme Court strikes down part or ... See all stories on this topic » | ||
| Genpact to manage Reddy's finances Daily News & Analysis By KV Ramana | Place: Hyderabad | Agency: DNA BPO firm Genpact has entered into an agreement with pharmaceuticals major Dr Reddy's Laboratories to provide comprehensive finance and accounting (F&A) services. Genpact will take over Dr Reddy's shared ... See all stories on this topic » | ||
| Teva lowers 2012 profit and revenue guidance Globes New Teva CEO Dr. Jeremy Levin said that the slowdown in Europe is hitting the pharmaceutical company's financial performance. During a conference call this afternoon, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) president and CEO Dr. See all stories on this topic » | ||
| Teva Pharm cuts 2012 sales, profit outlook Reuters Sees 2012 revenue $20-$21 bln, EPS ex-items $5.30-$5.40 * CEO says Europe to reduce revenue by $1 bln * CEO says would divest business that don't fit * Shares up 1 pct TEL AVIV, May 24 (Reuters) - Teva Pharmaceutical Industries , the world's largest ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment